The Efficacy of Retinoic Acid in Patients with Radioiodine-Refractory Thyroid Cancer: A Meta-analysis

被引：0
|
作者：
Shin, Seunghyeon [1 ]
Pak, Kyoungjune [1 ]
Kim, Seong-Jang [1 ]
Kim, In Joo [1 ]
机构：
[1] Pusan Natl Univ Hosp, Busan, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1702
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Lenvatinib and radioiodine-refractory thyroid cancers
    Dunn, Lara
    Fagin, James A.
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (06) : 325 - 327
  • [32] Redifferentiation of radioiodine-refractory thyroid cancers
    Buffet, Camille
    Wassermann, Johanna
    Hecht, Fabio
    Leenhardt, Laurence
    Dupuy, Corinne
    Groussin, Lionel
    Lussey-Lepoutre, Charlotte
    ENDOCRINE-RELATED CANCER, 2020, 27 (05) : R113 - R132
  • [33] Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer
    Choi, Sung-eun
    Pyo, Ju Yeon
    Kim, Ji-seop
    Shin, Eunah
    Hong, Soon W.
    MODERN PATHOLOGY, 2016, 29 : 147A - 148A
  • [34] Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer
    Choi, Sung-eun
    Pyo, Ju Yeon
    Kim, Ji-seop
    Shin, Eunah
    Hong, Soon Won
    LABORATORY INVESTIGATION, 2016, 96 : 147A - 148A
  • [35] Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer
    Krajewska, Jolanta
    Jarzab, Barbara
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (12): : 1331 - 1340
  • [36] Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer
    Hewett, Yvonne
    Ghimire, Subash
    Farooqi, Bilal
    Shah, Binay K.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 28 - 32
  • [37] THE EVPI OF TREATMENT STRATEGIES FOR RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
    Huang, W.
    Chen, L.
    Ting, J.
    Cao, V
    Sung, H.
    Yokokura, M.
    Wilson, L.
    VALUE IN HEALTH, 2016, 19 (07) : A886 - A886
  • [38] Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer
    Kiyota, Naomi
    Schlumberger, Martin
    Muro, Kei
    Ando, Yuichi
    Takahashi, Shunji
    Kawai, Yasukazu
    Wirth, Lori
    Robinson, Bruce
    Sherman, Steven
    Suzuki, Takuya
    Fujino, Katsuki
    Gupta, Anubha
    Hayato, Seiichi
    Tahara, Makoto
    CANCER SCIENCE, 2015, 106 (12) : 1714 - 1721
  • [39] Systemic treatments for radioiodine-refractory thyroid cancers
    Chen, Piaohong
    Yao, Yu
    Tan, Huiwen
    Li, Jianwei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [40] Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
    Shen, Huize
    Zhu, Rui
    Liu, Yanyang
    Hong, Yangjian
    Ge, Jiaming
    Xuan, Jie
    Niu, Wenyuan
    Yu, Xuefei
    Qin, Jiang-Jiang
    Li, Qinglin
    DRUG RESISTANCE UPDATES, 2024, 72
12345